Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
25
pubmed:dateCreated
2001-12-19
pubmed:abstractText
ICF (immunodeficiency, centromeric region instability and facial anomalies) is a recessive disease caused by mutations in the DNA methyltransferase 3B gene (DNMT3B). Patients have immunodeficiency, chromosome 1 (Chr1) and Chr16 pericentromeric anomalies in mitogen-stimulated lymphocytes, a small decrease in overall genomic 5-methylcytosine levels and much hypomethylation of Chr1 and Chr16 juxtacentromeric heterochromatin. Microarray expression analysis was done on B-cell lymphoblastoid cell lines (LCLs) from ICF patients with diverse DNMT3B mutations and on control LCLs using oligonucleotide arrays for approximately 5600 different genes, 510 of which showed a lymphoid lineage-restricted expression pattern among several different lineages tested. A set of 32 genes had consistent and significant ICF-specific changes in RNA levels. Half of these genes play a role in immune function. ICF-specific increases in immunoglobulin (Ig) heavy constant mu and delta RNA and cell surface IgM and IgD and decreases in Ig(gamma) and Ig(alpha) RNA and surface IgG and IgA indicate inhibition of the later steps of lymphocyte maturation. ICF-specific increases were seen in RNA for RGS1, a B-cell specific inhibitor of G-protein signaling implicated in negative regulation of B-cell migration, and in RNA for the pro-apoptotic protein kinase C eta gene. ICF-associated decreases were observed in RNAs encoding proteins involved in activation, migration or survival of lymphoid cells, namely, transcription factor negative regulator ID3, the enhancer-binding MEF2C, the iron regulatory transferrin receptor, integrin beta7, the stress protein heme oxygenase and the lymphocyte-specific tumor necrosis factor receptor family members 7 and 17. No differences in promoter methylation were seen between ICF and normal LCLs for three ICF upregulated genes and one downregulated gene by a quantitative methylation assay [combined bisulfite restriction analysis (COBRA)]. Our data suggest that DNMT3B mutations in the ICF syndrome cause lymphogenesis-associated gene dysregulation by indirect effects on gene expression that interfere with normal lymphocyte signaling, maturation and migration.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0964-6906
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2917-31
pubmed:dateRevised
2010-5-21
pubmed:meshHeading
pubmed-meshheading:11741835-Cell Line, pubmed-meshheading:11741835-Chromosomes, Human, Pair 1, pubmed-meshheading:11741835-Chromosomes, Human, Pair 16, pubmed-meshheading:11741835-DNA (Cytosine-5-)-Methyltransferase, pubmed-meshheading:11741835-DNA Methylation, pubmed-meshheading:11741835-Flow Cytometry, pubmed-meshheading:11741835-Gene Expression Profiling, pubmed-meshheading:11741835-Gene Expression Regulation, pubmed-meshheading:11741835-Humans, pubmed-meshheading:11741835-Immunologic Deficiency Syndromes, pubmed-meshheading:11741835-Lymphocytes, pubmed-meshheading:11741835-Membrane Proteins, pubmed-meshheading:11741835-Mutation, pubmed-meshheading:11741835-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:11741835-Phenotype, pubmed-meshheading:11741835-Promoter Regions, Genetic, pubmed-meshheading:11741835-RNA, pubmed-meshheading:11741835-Syndrome
pubmed:year
2001
pubmed:articleTitle
DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes.
pubmed:affiliation
Human Genetics Program and Department of Biochemistry, Tulane Medical School, New Orleans, LA 70112, USA. ehrlich@tulane.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.